medigraphic.com
ISSN 1028-4818 (Electronic)

2016, Number 3

<< Back Next >>

Mul Med 2016; 20 (3)

Hemolytic disease of the newborn by isoimmunization to minor blood groups. A weird case

Ferrer MR, Laurenzo GBC, Ávila SEA

Language: Spanish
References: 10
Page: 624-630
PDF size: 179.02 Kb.


ABSTRACT

Hemolytic disease of the fetus and the newborn is an isoimmune immunologic disease, frequently seen in cases of ABO incompatibility groups, less frequent in Rh groups incompatibility cases and they are even less frequent in cases on incompatibility to minor blood groups. We report the case of an 8 days old female newborn with blood group and Rh compatible to her mother, transferred to our hospital because of jaundice with serum levels of high bilirrubin and severe anemia. Before the hematological research it was carried out the phototherapy and also blood transfusions. Later studies confirmed that the hemolytic anemia and jaundice were due to irregular anti-bodies anti C and anti Cw. The hemolysis decreased gradually, the evolution of the newborn was favorable and the patient was discharged with a normal hematic byometry and without any further problems. This case reminds us that with the declination of the hemolytic anemia due to Rh incompatibility, it has to be taken into consideration the jaundice and secondary hemolysis to unusual or minor groups.


REFERENCES

  1. Mazzi E. Ictericia neonatal. En: Mazzi E, Sandoval O, eds. Perinatología. 2da. Ed. La Paz: Elite Impresiones; 2002. p. 483-501.

  2. López de Roux MR, Cortina L. Enfermedad Hemolítica Perinatal. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2000 [Citado 20 de noviembre del 2015]; 16(3):161-83. Disponible en: http://www.bvs.sld.cu/revistas/hih/vol16_3_00/hih02300.htm

  3. Creasy RK, Resnik R, Iams JD. Maternal-Fetal Medicine: Principles and Practice. Philadelphia: Saunders; 2008.

  4. Rennie JM. Textbook of Neonatology. NRC. Australia: Elsevier Churchill Livingstone; 2009.

  5. Martin RJ, Fanaroff AA, Walsh MC. Care of the high-risk neonate. Philadelphia: Saunders; 2006.

  6. Madero L, Muñoz Villa A. Hematología y Oncología Pediátricas. 2a ed. Madrid: Ergón; 2010.

  7. Moise KJ Jr. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol [Internet]. 2008 [Citado 21 de noviembre del 2015]; 198(2). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18226612

  8. De Boer IP, Zeestraten ECM, Lopriore E, et al. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion. Am J Obstet Gynecol [Internet]. 2008 [Citado 25 de noviembre del 2015]; 198(1):54-e1-4. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18166305

  9. Grustin AM, Moore TR. Eritroblastosis fetalis. In: Martin R, Fanaroff A, Walsh M. eds. Neonatol. Perinatol Medicine. 9th ed. Philadelphia, Pa; Mosby Elsevier; 2011.

  10. Laitano Gina. Enfermedad hemolítica del recién nacido por antieritrocitarios maternos. Revista Ciencia y Tecnología [Internet]. 2013 [citado 11 de diciembre del 2015]; (12). Disponible en: http://www.lamjol.info/index.php/RCT/article/view/1706




2020     |     www.medigraphic.com